Mr. Speaker, I have the honour to present in both official languages the 11th report of the Standing Committee on Public Accounts in relation to its study of Chapter 4—Regulating Pharmaceutical Drugs—Health Canada of the fall 2011 report of the Auditor General of Canada.
Pursuant to Standing Order 109 of the House of Commons, the committee requests that the government table a comprehensive response to this report.